31
Jul
Sanofi Consumer Healthcare India Limited reported a steady financial performance for the second quarter of FY26, posting a 7% year-on-year rise in revenue to ₹2,357 million, supported by robust domestic demand and improved profitability despite softer export sales. The company said domestic sales grew 12% during the quarter, driven by its product relaunch strategy, while export sales declined 9% due to a high base in the corresponding period last year. Profit Before Tax (PBT) increased 16% year-on-year to ₹919 million, reflecting stronger operational execution and disciplined cost management. For the first half of FY26, Sanofi Consumer Healthcare India recorded revenue…
